BSFA - Ticker AI Digest

BSF Enterprise Plc 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (BSFA) 1
BSFA 06:01
BSF Enterprise Plc
Annual Financial Report
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of BSF Enterprise PLCs Annual Financial Report (2025):**
BSF Enterprise PLC, a leader in tissue-engineered materials, released its Annual Report for the year ended September 30, 2025, highlighting significant progress across its subsidiaries and strategic initiatives.
**Key Highlights**
1. **Commercial and Technical Progress**
Subsidiaries 3D Bio-Tissues (3DBT), Lab-Grown Leather (LGL), and Kerato achieved notable advancements.
Launched CytoBoostâ„¢ bioactive media additive and expanded City-Mixâ„¢ for cost-effective cultivated meat production.
Developed the worlds first 2mm-thick scaffold-free leather, collaborating with luxury fashion brands.
Secured a licensing agreement with the University of Montreal for liquid cornea technology, with veterinary trials planned for 2026 and human trials in 2027.
2. **Financial Performance**
Reduced net loss to £1,013,527 (from £1,672,291 in 2024) due to cost control and increased grant income.
Strategic fundraising initiatives, including shareholder approval for up to £15 million via warrants, to support commercialization, spin-outs, and expansion in Greater China.
3. **Strategic Achievements**
Expanded into Greater China, laying the foundation for local cultivated meat production.
Strengthened sustainability and ESG commitments, aligning with the Task Force on Climate-Related Financial Disclosures (TCFD).
4. **Future Plans (2026)**
Commercialize CytoBoost™ and City-mixⓇ.
Scale up lab-grown leather production and produce T-Rex leather for sale.
Complete veterinary clinical trials for corneal implants, advancing toward human trials in 2027.
Expand cultivated meat production in Greater China.
Explore acquisitions of compatible businesses.
**Financial Summary**
Revenue: £52840 (2024: £57821)
Loss before taxation: £1216970 (2024: £1797506)
Loss for the year: £1113527 (2024: £1672291)
Cash and cash equivalents: £149020 (2024: £637656)
**Corporate Governance and Sustainability:**
Committed to ethical valuesshareholder engagementand sustainability.
Adopted anti-bribery and anti-corruption policies.
Focused on diversity and environmental responsibility, aligning with TCFD recommendations.
**Conclusion**
BSF Enterprise PLC demonstrated significant progress in 2025, with strategic advancements, reduced losses, and a clear roadmap for 2026. The company is well-positioned for long-term growth in sustainable, tissue-engineered materials, supported by strong governance and sustainability commitments.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 1
BSFA 06:01
BSF Enterprise Plc
Annual Financial Report
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of BSF Enterprise PLCs Annual Financial Report (2025):**
BSF Enterprise PLC, a leader in tissue-engineered materials, released its Annual Report for the year ended September 30, 2025, highlighting significant progress across its subsidiaries and strategic initiatives.
**Key Highlights**
1. **Commercial and Technical Progress**
Subsidiaries 3D Bio-Tissues (3DBT), Lab-Grown Leather (LGL), and Kerato achieved notable advancements.
Launched CytoBoostâ„¢ bioactive media additive and expanded City-Mixâ„¢ for cost-effective cultivated meat production.
Developed the worlds first 2mm-thick scaffold-free leather, collaborating with luxury fashion brands.
Secured a licensing agreement with the University of Montreal for liquid cornea technology, with veterinary trials planned for 2026 and human trials in 2027.
2. **Financial Performance**
Reduced net loss to £1,013,527 (from £1,672,291 in 2024) due to cost control and increased grant income.
Strategic fundraising initiatives, including shareholder approval for up to £15 million via warrants, to support commercialization, spin-outs, and expansion in Greater China.
3. **Strategic Achievements**
Expanded into Greater China, laying the foundation for local cultivated meat production.
Strengthened sustainability and ESG commitments, aligning with the Task Force on Climate-Related Financial Disclosures (TCFD).
4. **Future Plans (2026)**
Commercialize CytoBoost™ and City-mixⓇ.
Scale up lab-grown leather production and produce T-Rex leather for sale.
Complete veterinary clinical trials for corneal implants, advancing toward human trials in 2027.
Expand cultivated meat production in Greater China.
Explore acquisitions of compatible businesses.
**Financial Summary**
Revenue: £52840 (2024: £57821)
Loss before taxation: £1216970 (2024: £1797506)
Loss for the year: £1113527 (2024: £1672291)
Cash and cash equivalents: £149020 (2024: £637656)
**Corporate Governance and Sustainability:**
Committed to ethical valuesshareholder engagementand sustainability.
Adopted anti-bribery and anti-corruption policies.
Focused on diversity and environmental responsibility, aligning with TCFD recommendations.
**Conclusion**
BSF Enterprise PLC demonstrated significant progress in 2025, with strategic advancements, reduced losses, and a clear roadmap for 2026. The company is well-positioned for long-term growth in sustainable, tissue-engineered materials, supported by strong governance and sustainability commitments.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 2
BSFA 06:01
BSF Enterprise Plc
Annual Financial Report
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of BSF Enterprise PLCs Annual Financial Report (2025):**
BSF Enterprise PLC, a leader in tissue-engineered materials, released its Annual Report for the year ended September 30, 2025, highlighting significant progress across its subsidiaries and strategic initiatives.
**Key Highlights**
1. **Commercial and Technical Progress**
Subsidiaries 3D Bio-Tissues (3DBT), Lab-Grown Leather (LGL), and Kerato achieved notable advancements.
Launched CytoBoostâ„¢ bioactive media additive and expanded City-Mixâ„¢ for cost-effective cultivated meat production.
Developed the worlds first 2mm-thick scaffold-free leather, collaborating with luxury fashion brands.
Secured a licensing agreement with the University of Montreal for liquid cornea technology, with veterinary trials planned for 2026 and human trials in 2027.
2. **Financial Performance**
Reduced net loss to £1,013,527 (from £1,672,291 in 2024) due to cost control and increased grant income.
Strategic fundraising initiatives, including shareholder approval for up to £15 million via warrants, to support commercialization, spin-outs, and expansion in Greater China.
3. **Strategic Achievements**
Expanded into Greater China, laying the foundation for local cultivated meat production.
Strengthened sustainability and ESG commitments, aligning with the Task Force on Climate-Related Financial Disclosures (TCFD).
4. **Future Plans (2026)**
Commercialize CytoBoost™ and City-mixⓇ.
Scale up lab-grown leather production and produce T-Rex leather for sale.
Complete veterinary clinical trials for corneal implants, advancing toward human trials in 2027.
Expand cultivated meat production in Greater China.
Explore acquisitions of compatible businesses.
**Financial Summary**
Revenue: £52840 (2024: £57821)
Loss before taxation: £1216970 (2024: £1797506)
Loss for the year: £1113527 (2024: £1672291)
Cash and cash equivalents: £149020 (2024: £637656)
**Corporate Governance and Sustainability:**
Committed to ethical valuesshareholder engagementand sustainability.
Adopted anti-bribery and anti-corruption policies.
Focused on diversity and environmental responsibility, aligning with TCFD recommendations.
**Conclusion**
BSF Enterprise PLC demonstrated significant progress in 2025, with strategic advancements, reduced losses, and a clear roadmap for 2026. The company is well-positioned for long-term growth in sustainable, tissue-engineered materials, supported by strong governance and sustainability commitments.
BSFA 06:01
BSF Enterprise Plc
KERATO LIMITED SIGNS WITH QUEBEC PSO GRANT

AI Crunch

Single-Ticker AI Crunch
BSFA signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for BSF Enterprise Plc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full BSFA AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for BSFA on 2026-02-02.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
2297902
Enterprise Value
711650
Public Float
5.7
Broker Target
-
Shares Out
128374428
Long Interest
100
Short Interest
-
Exchange
LSE
Currency Code
GBX
ISIN
GB00BHNBDQ51
Market
LSE - MAIN MARKET
Sector
Health Care
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
-
Net Debt
-149020.0
Cash
149020.0
EPS
-0.01
Net Income
-1113527.0
Revenue
52840.0
Enterprise Value
711650
Trailing PE
-
Forward PE
-
Price Sales TTM
43.4879
Price Book MRQ
0.0787
EV Revenue
1.2289
EV EBITDA
-13.1193

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
128374428
Public Hands
5.7
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
3
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit BSFA.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2026-02-02 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
BSF Enterprise Plc has fresh news flow feeding the chart narrative.
AI Charts Studio
BSFA Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-02-02 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast -68.00%
RSI Gauge
Price Change
AI Forecast